Resona Asset Management Co. Ltd. Has $11.90 Million Position in Agilent Technologies, Inc. $A

Resona Asset Management Co. Ltd. lessened its stake in Agilent Technologies, Inc. (NYSE:A) by 5.2% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 93,295 shares of the medical research company’s stock after selling 5,105 shares during the period. Resona Asset Management Co. Ltd.’s holdings in Agilent Technologies were worth $11,902,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Capital A Wealth Management LLC boosted its holdings in Agilent Technologies by 10,600.0% in the second quarter. Capital A Wealth Management LLC now owns 214 shares of the medical research company’s stock valued at $25,000 after acquiring an additional 212 shares during the last quarter. Davis Capital Management bought a new position in Agilent Technologies during the 3rd quarter worth approximately $28,000. State of Wyoming acquired a new position in shares of Agilent Technologies in the 2nd quarter worth approximately $35,000. SJS Investment Consulting Inc. lifted its position in shares of Agilent Technologies by 2,836.4% in the 3rd quarter. SJS Investment Consulting Inc. now owns 323 shares of the medical research company’s stock worth $41,000 after purchasing an additional 312 shares during the period. Finally, Salomon & Ludwin LLC increased its position in shares of Agilent Technologies by 242.5% during the third quarter. Salomon & Ludwin LLC now owns 363 shares of the medical research company’s stock worth $51,000 after buying an additional 257 shares during the period.

Insider Buying and Selling at Agilent Technologies

In other news, CEO Padraig Mcdonnell sold 12,490 shares of the business’s stock in a transaction dated Wednesday, November 12th. The shares were sold at an average price of $150.00, for a total transaction of $1,873,500.00. Following the completion of the sale, the chief executive officer directly owned 33,448 shares of the company’s stock, valued at $5,017,200. The trade was a 27.19% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, VP Rodney Gonsalves sold 3,000 shares of the firm’s stock in a transaction dated Wednesday, November 26th. The shares were sold at an average price of $154.99, for a total transaction of $464,970.00. Following the completion of the transaction, the vice president directly owned 31,846 shares in the company, valued at approximately $4,935,811.54. The trade was a 8.61% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 16,401 shares of company stock worth $2,468,962.

Agilent Technologies Stock Performance

Shares of A opened at $134.90 on Monday. Agilent Technologies, Inc. has a one year low of $96.43 and a one year high of $160.27. The company has a market cap of $38.25 billion, a PE ratio of 29.52, a P/E/G ratio of 3.92 and a beta of 1.29. The stock has a 50-day moving average of $143.36 and a 200-day moving average of $134.14. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.96 and a quick ratio of 1.52.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Monday, November 24th. The medical research company reported $1.59 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.58 by $0.01. The business had revenue of $1.86 billion for the quarter, compared to analyst estimates of $1.83 billion. Agilent Technologies had a return on equity of 25.20% and a net margin of 18.75%.The company’s quarterly revenue was up 9.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.46 earnings per share. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. On average, equities research analysts predict that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.

Agilent Technologies Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 28th. Shareholders of record on Tuesday, January 6th will be paid a dividend of $0.255 per share. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.25. The ex-dividend date is Tuesday, January 6th. This represents a $1.02 dividend on an annualized basis and a yield of 0.8%. Agilent Technologies’s dividend payout ratio (DPR) is presently 22.32%.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the stock. Citigroup boosted their target price on shares of Agilent Technologies from $165.00 to $185.00 and gave the company a “buy” rating in a report on Tuesday, November 25th. The Goldman Sachs Group started coverage on Agilent Technologies in a research report on Tuesday, December 9th. They issued a “buy” rating and a $170.00 price objective for the company. Robert W. Baird upped their target price on Agilent Technologies from $142.00 to $165.00 and gave the company an “outperform” rating in a research report on Tuesday, November 25th. Bank of America lifted their target price on Agilent Technologies from $150.00 to $165.00 and gave the stock a “neutral” rating in a report on Tuesday, November 25th. Finally, Rothschild & Co Redburn started coverage on Agilent Technologies in a research note on Wednesday, October 8th. They issued a “buy” rating and a $165.00 price target on the stock. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, Agilent Technologies presently has a consensus rating of “Moderate Buy” and a consensus target price of $164.50.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.